Advertisement

U.S. markets open in 3 hours 24 minutes

S&P Futures
4,234.50
+24.75(+0.59%)
Dow Futures
33,476.00
+172.00(+0.52%)
Nasdaq Futures
13,401.50
+90.25(+0.68%)
Russell 2000 Futures
1,990.60
+14.30(+0.72%)
Crude Oil
94.60
+0.26(+0.28%)
Gold
1,802.60
-4.60(-0.25%)

Advertisement

Cresco Labs Inc. (CRLBF)

Other OTC - Other OTC Delayed Price. Currency in USD

Add to watchlist

3.5800

+0.0600

(+1.70%)

At close: 03:59PM EDT

Advertisement

Full screen

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Chart Events

Neutralpattern detected

View all chart patterns

Performance Outlook

Previous Close	3.5200
Open	3.5300
Bid	0.0000 x 0
Ask	0.0000 x 0
Day's Range	3.5284 - 3.6700
52 Week Range	2.4200 - 11.1460
Volume	380,578
Avg. Volume	437,395

Market Cap	1.043B
Beta (5Y Monthly)	2.14
PE Ratio (TTM)	N/A
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.

Fair Value

XX.XX

N/A

Subscribe to Yahoo Finance Plus to view Fair Value for CRLBF

View details

Research that delivers an independent perspective, consistent methodology and actionable insight

Related Research

CRESCO LABS INC
Analyst Report: Curaleaf Holdings, Inc.Curaleaf is headquartered in Wakefield, Massachusetts, and cultivates and sells medicinal and recreational cannabis in the U.S. The company has operations in 22 states, including the assets from the Cura Select and Grassroots acquisitions. Its brands include Curaleaf, UKU, Select, and Grassroots. The company acquired EMMAC Life Sciences in March 2021, beginning its foray into the global medical market in competition with Canadian cannabis producers.
Rating
Fair Value
Economic Moat
3 days agoMorningstar